A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

NCT07123103 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Exelixis